Stem cell bank

Abstract

The present disclosure is related to methods for forming a stem cell bank. The methods include obtaining a first stem cell from a multi-cell fertilized embryo, expanding the first stem cell into two or more descendant stem cells, and storing at least one of the descendant stem cells to form the stem cell bank. Also disclosed is a kit that can be used for making the stem cell bank during in vitro fertilization. If desired, the HLA serotype of the stem cells can be determined prior to storage.

1 . A HLA typed stem cell bank, comprising:
 a cryopreservation medium;   a first cryotube including a first derived stem cell line representative of a first HLA serotype; and   an infrastructure housing the cryopreservation medium and the first cryotube.   
     
     
         2 . The stem cell bank of  claim 1 , wherein the first representative HLA-type is homozygous for either HLA-A, HLA-B, or HLA-DR. 
     
     
         3 . The stem cell bank of  claim 1 , further including a second cryotube within the infrastructure, the second cryotube including a second derived stem cell representative of a second HLA-type, wherein the second HLA-type is different than the first HLA-type. 
     
     
         4 . A method for forming a stem cell bank, comprising:
 obtaining a first stem cell from a multi-cell fertilized embryo;   expanding the first stem cell into two or more descendant stem cells; and   storing at least one of the descendant stem cells to form the stem cell bank.   
     
     
         5 . The method of  claim 4 , wherein the first stem cell is expanded by placing the first stem cell on a cell culture substrate comprising a laminin and a cadherin, wherein the laminin is an intact protein or a protein fragment. 
     
     
         6 . The method of  claim 5 , wherein the laminin is laminin-521 or laminin-511. 
     
     
         7 . The method of  claim 5 , wherein the cadherin is e-cadherin. 
     
     
         8 . The method of  claim 5 , wherein the weight ratio of the laminin to the cadherin is from about 5:1 to about 15:1. 
     
     
         9 . The method of  claim 4 , wherein the cell culture substrate does not contain any differentiation inhibitors, feeder cells, differentiation inductors, or apoptosis inhibitors. 
     
     
         10 . The method of  claim 4 , further including applying a cell culture medium to the first stem cell. 
     
     
         11 . The method of  claim 10 , wherein the cell culture medium has an albumin concentration of at least 0.3 mM. 
     
     
         12 . The method of  claim 4 , further comprising replating the descendant stem cells on a new cell culture substrate comprising a laminin, wherein the laminin is an intact protein or a protein fragment. 
     
     
         13 . The method of  claim 4 , wherein the multi-cell fertilized embryo has from 8 to 32 total cells. 
     
     
         14 . The method of  claim 4 , further comprising determining the human leukocyte antigen (HLA) serotype of the first stem cell or the two or more descendant stem cells 
     
     
         15 . The method of  claim 14 , wherein determining the HLA serotype includes determining whether the two or more descendant stem cells are homozygous at a given HLA locus. 
     
     
         16 . The method of  claim 15 , wherein the given HLA locus is the HLA-A, HLA-B, or DR locus. 
     
     
         17 . The method of  claim 14 , wherein the HLA serotype is determined by PCR-SSO.